成都中医如何治疗静脉血栓好-【成都川蜀血管病医院】,成都川蜀血管病医院,成都有几个静脉曲张医院,成都肝血管瘤手术大约要多少钱,成都海绵状血管瘤去看什么科,成都治疗血管畸形,成都最好的血糖足医院是哪个医院,成都哪个医院可以做精索静脉曲张微创
成都中医如何治疗静脉血栓好成都血管畸形如何医治,精索静脉曲张成都有什么专科医院,成都精索静脉曲张那些医院比较好,成都婴幼儿血管瘤什么科,成都治疗静脉曲张的价格,成都精索静脉曲张的专业医院,成都治静脉血栓需多少钱
BEIJING, Sept. 4 (Xinhua) -- China's railway system has transported some 1.27 billion passengers during the first eight months of this year, up 11.8 percent from a year earlier, the Ministry of Railways said Sunday.The figure has accounted for 67.4 percent of the ministry's full-year target, said the ministry in a statement on its website.The Ministry of Railways has planned to send 1.9 billion passengers in 2011, up 13.1 percent year-on-year.The country's high-speed trains had been operating with improved order and efficiency, said the ministry, which has been required to run high-speed trains at slower speeds, as well as to reorganize bullet train schedules nationwide, for safety reasons.The State Council, or Cabinet, ordered increased safety checks after a fatal train collision that killed 40 people in July raised concerns over the safety of the country's high-speed railways.The ministry cut the number of high-speed trains running between Beijing and Shanghai to 66 pairs from 88 pairs per day, effective as of Aug. 16.Meanwhile, the railways transported more than 2.6 billion metric tons of goods from January to August, up 7.8 percent year-on-year, the ministry said.
BEIJING, Aug. 18 (Xinhua) -- A controlled trial has found that Chinese herbal medicine decoction maxingshigan-yinqiaosan has a similar efficacy to oseltamivir in reducing time to fever resolution in people suffering mild H1N1 influenza virus infections.Carried out by a group of Chinese researchers, headed by Prof. Wang Chen with Beijing Chao-Yang Hospital under the Capital Medical University, the study was published by the famous internal medicine journal Ann Intern Med on Tuesday.Participants of the trial were 410 young adults aged 15 to 59 years with laboratory-confirmed H1N1 influenza.The researchers concluded that both active intervention, alone and in combination, were effective in reducing time to fever resolution in young adults with H1N1 flu, and therefore suggest that maxingshigan-yinqiaosan may be an alternative to oseltamivir.
BEIJING, June 27 (Xinhuanet) -- A "lean gene" that helps people keep slim was found closely related to diabetes and heart disease, according to a study pulished in Nature Genetics journal on Sunday.The scientists from Britain’s Medical Research Council Epidemiology Unit conducted the study.After comparing the genetic codes of more than 75,000 people, a gene called IRS1 was spotted as the decisive factor to lower the fat level in human body.But in further study, IRS1 was found putting people to a 20 percent higher risk of developing heart disease and type-2 diabetes.The study warned that people who appear slim and fit might be also at risk.But scientists suggest that the study results did not change the general message for most people."While this study pointed to genes as one factor in determining the risk of developing these conditions, it was important to remember that lifestyle factors like diet, exercise, cutting out smoking and maintaining a healthy weight also play a vital role in reducing the risk," said Ruth Loos, who led the study.
HOHHOT, July 8 (Xinhua) -- The 3rd Happy Grassland Fitness Day will kick off 16 August in Chifeng city, north China's Inner Mongolia Autonomous Region.12 cities and leagues in the region will send athletes to compete in 4 sports including Mongolian wrestling, Mongolian archery, table tennis and badminton.The activity was jointly held by the regional sports department and Chifeng sports department.
BEIJING, Sep. 13 (Xinhuanet) --Experts have called for a national drug-control system after a nationwide deficit of a life-saving drug, which has lasted at least three months.Doctors at a Beijing hospital said some specialized hospitals, which perform hundreds of cardiac operations every month, have been paralyzed by their lack of protamine sulfate, which is commonly administered after heart surgery to reverse the anticoagulant effects of heparin.The earliest report of a shortage was in Hubei province on July 21. This was followed by reports of shortages in Guangdong, Shandong and Liaoning provinces.The Shandong newspaper, Qilu Evening News, quoted a regional sales manager, surnamed Zhuang, as saying the province had been allocated 150 doses of protamine sulfate after Shanghai No 1 Biochemical and Pharmaceutical Co Ltd recently resumed production of the drug."But its monthly use here is usually 10,000 doses," he said.The Ministry of Health has denied it is responsible for supplies of the drug and passed the buck to the State Food and Drug Administration, claiming the latter is responsible for the supervision of medicines.Shen Chen, head of the publicity office of the State Food and Drug Administration, said he was unaware of the shortage, but said the administration is responsible for the quality of medicines, not the supply."Development and reform authorities oversee the medicines' prices, while the industrial and commercial authorities oversee the storage. The food and drug departments only cover the approval and quality of medicines."Industry insiders said one of the reasons for the shortage was the low profit margin, which discourages companies from mass producing the drug."Some companies can't earn enough to recover their costs, therefore it is almost impossible to maintain their enthusiasm for continuing production," said Lu Guoping, secretary-general of the Shanghai Pharmaceutical Trade Association.Lu said the government should issue policies to prevent future shortages of such medicines to avoid possible nationwide public health incidents.Yi Shenghua, a lawyer at Beijing Yingke Law Firm, said the country should have a unified system to guarantee the normal supply of medicines that are widely used and drug manufacturers should fulfill their responsibilities to society, even though there is no law stipulating they should produce specific medicines.He came up with two ways to deal with the problem of companies only producing profitable drugs."The government can order businesses to manufacture a certain amount of cheap medicines. Or it can offer financial assistance to subsidize cheap, but life-saving medicines."